Overview

Patrick C. Diaz is an associate in the Corporate Practice Group in the firm's Washington, D.C. office. 

Areas of Practice

Patrick represents private equity sponsors, their platform companies and private companies in leveraged buyouts, M&A transactions and general corporate governance matters. For M&A transactions, his experience includes asset purchases, equity purchases, mergers and carve-outs both on the buy-side and the sell-side. Patrick represents clients in the aerospace and defense, government services, technology services, and healthcare services industries.

Patrick also helps both private equity portfolio companies and venture-backed startups with corporate governance on their capitalization tables, equity financings, director, manager and officer slates, corporate filings, and other corporate governance matters.

Before joining Sheppard Mullin, Patrick worked in the technology industry at SAP and Tata Consultancy Services, where he led its AI practice on Microsoft in North America.

Experience

Experience

  • Represented Arlington Capital Partners in its acquisition of Avenu Insights & Analytics from Mill Point Capital (2023) and represented Avenu in its (i) acquisition of Justice Systems and Columbia Ultimate Business Systems, providers of payment services to state and local governments from Finvi (2024), (ii) merger with Intellectual Technology Inc., a leading provider of DMV software and services (2025), and (iii) acquisition of GovOS, a leading provider of tax and licensing software from Audax Private Equity (2025). Through this series of acquisitions, Arlington Capital Partners and Avenu formed Neumo, a new leader in integrated software and payments solutions for local, state, and federal governments.
  • Represented Atlas Space Operations, a pioneer in Ground Software as a Service for satellite communications, in its sale to affiliates of York Space Systems.
  • Represented Precision Medicine Group in its (i) acquisition of Baseline Controls, an engineering services company serving the life sciences industry (2023), (ii) acquisition of Algorics, Inc., a leading provider of biostatistics, clinical data management and statistical programming for clinical trials, and its Indian affiliate (2023), and (iii) divestiture of Project Farma, a leading life sciences consultancy to PerkinElmer (2025).
  • Represented COEX Partners, a TP ICAP company, in its acquisition of the credit business of Cambridge International Securities, a US- and UK-based independent fixed income broker-dealer.
  • Represented Tex-Tech Industries, Inc., a portfolio company of Arlington Capital Partners, in its acquisition of Fiber Materials Inc., an industry leader in high-temperature materials and reinforced composites, from Spirit AeroSystems Holdings Inc. (NYSE: SPR).
  • Represented Arlington Capital Partners in connection with its sale of J&J Worldwide Services, a leading provider of facility management, operational support and integrated asset management services for the Department of Defense and other components of U.S. Federal Government, to CBRE Group Inc. (NYSE: CBRE)
  • Represented Systems Planning and Analysis, a portfolio company of Arlington Capital Partners, in its acquisition of PRKK, a provider of consulting services to customers in defense, intelligence and critical civilian governmental agencies.
  • Represented Leia, Inc. in its acquisition of Dimenco, a Dutch 3D display hardware startup.
  • Represented DartPoints, a leading provider of colocation, cloud, and cybersecurity services for edge markets, in its acquisition of Venyu, Louisiana's premier data center infrastructure and cloud services provider from EATEL.
  • Represented the senior executive team of Maxor (a national pharmacy services company) in connection with the acquisition of the company by Towerbrook Capital Partners.

Insights

Articles

AI Law and Policy Blog Posts

Education

J.D., Emory University, 2022, with honors 

B.A., College of William & Mary, 2013

Admissions

  • District of Columbia 
  • Maryland 
Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.